Match Patients with Suitable Clinical Trials at the Point of Care
BRIDGE THE GAP BETWEEN PATIENT CARE AND RESEARCH
Trial Navigator Patient View Module auto-identifies patients eligible for pre-screening and places these insights directly within clinicians’ workflows. This saves oncologists, nurses and ther clinicians hours of manual effort and ensures every suitable patient gets access to cutting-edge treatments.
Why Healthcare Providers Choose Inspirata: By the Numbers
Leading Hospitals Trust Inspirata
Pathology, Radiology, and Related Medical Records Processed Annually
Customer Retention Rate
Put Your Organization at the Forefront of Patient-Centered Care
Clinicians spend hours manually sifting through medical documents to match patients with suitable clinical trials. But this is not only inefficient – it leads many patients to miss out on trials they were eligible for.
Trial Navigator Patient View Module equips clinicians with timely information about patients’ suitability for clinical trials, enabling them to:
Eliminate Bias
Elevate Patient Experience
Improve Patient Outcomes
Point of Care Trial Matching
- Integrate your EHR
The Patient View Module integrates seamlessly with your EHR, enabling trial suitability data to appear within clinicians’ normal workflow. - Analyze patient cohorts
The tool then uses AI to analyze all eligible oncology patient profiles within your institution and those new to center, assessing which patients align with the inclusion criteria for trials currently running at your sites. - Identify suitable patients
It then produces a “Match Score” that measures how well suited each patient is to a given trial – and delivers these insights directly within the patient chart. This lets clinicians instantly view which trials their current patient is suitable form and invite them to participate.
Give Every Eligible Patient Access to Clinical Trials
Manual identification processes lead to slow clinical trial matching and a disconnected experience for patients.
Use Trial Navigator Patient View Module to make access to clinical trials a standard part of your best-in-class cancer care.